ABSTRACT. Inhibition of Pseudomonas cepacia (but not Pseudomonas aeruginosa) by &lactams was decreased in 5% C 0 2 in air compared with air alone. The effect of C 0 2 and p H (range, 6.0 to 8.0) on 8-lactam susceptibility, 8-lactamase expression, and outer membrane proteins was studied in isolates recovered from the sputum of children with cystic fibrosis. Incubation in 5% COz decreased the activity of piperacillin, piperacillin/tazobactam, and ceftazidime, although isolates were still clinically sensitive (minimum inhibitory concentrations < 16 mg/L). Cefpirome activity was markedly decreased from a minimum inhibitory concentration of 2.0 to greater than 64 mg/L. On highly buffered 3-(N-morpho1ino)-propane sulfonic acid media, b-lactam susceptibility was eliminated at pH greater 7.5. A 2-to 13-fold increase in @-lactamase activity was demonstrated after growth in 5% C 0 2 compared with basal aerobic levels for 13 of 15 clinical isolates. 8-Lactamase activity did not vary significantly with pH. Addition of imipenem to media (2.0 mg/L) resulted in hyperproduction of 8-lactamase (180-fold). Isoelectric points varied with cultural conditions, and all 8-lactamases detected were inhibited by clavulanate and tazobactam. Significant hydrolysis of piperacillin and ceftazidime could not be demonstrated. A 36-kD porin was present a t all pII tested. Thus, our strains of Pseudomonas cepacia were markedly affected by cultural conditions not normally used in standardized susceptibility tests. However, such conditions may be encountered in the pathologically altered infected lung in cystic fibrosis. (Pediatr Res 35: [299][300][301][302] 1994) Abbreviations O M P , outer membrane protein MIC, minimum inhibitory concentration MOPS, 3-(N-morpholino)-propane sulfonic acid HBMM, highly buffered M O P S media IS0, concentration of inhibitor required to inhibit enzymatic activity by 50% under defined assay conditions
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Pselidomonas cepacia has emerged as an important opportunist pathogen in pulmonary infections in children with cystic fibrosis (1-3) and its appearance is associated with increased morbidity and mortality (2) resistant to many antimicrobial classes, including P-lactams, polymyxins, aminoglycosides, and quinolones. With some Plactams, even when in vitro activity was demonstrable, it was not translated into clinical efficacy (3) . Lack of in viva activity in this difficult-to-treat group of patients has been attributed to a variety of factors, including reduced permeation of antibiotic across bronchial mucosa, poor perfusion into all areas of the lung, high infecting inocula (>lo7 bacteria/mL), impaired phagocytosis, and antibiotic inactivation by pus (3) .
The possibility that this particular microorganism may respond differently to @-lactams in viva, compared with that demonstrated in the artificial environment of in vitro laboratory susceptibility tests, has not been investigated previously. We report the effect of alterations in C 0 2 concentration and pH on the susceptibility of P. ccpacia to P-lactams and their effect on bacterial P-lactamases and outer membrane proteins.
MATERIALS AND METHODS
Test strains. Fifteen isolates of P. cepacia recovered from the sputum of 15 children admitted to Alder Hey Children's Hospital with cystic fibrosis were studied. All isolates were identified by growth at 30°C with a commercial identification kit (API, Basingstoke, UK). Detailed findings are presented only for I-'. cc7pacia (laboratory code PC7) as our typical isolate. P. acrlrgirzosa NCTC 10662 was used to control susceptibility testing. Escschcrichia coli NCTC 104 18 and Staph~~locucc~is alirelts NCTC 657 1 were used as controls to determine @-lactam hydrolysis profiles (4). @-Lactamases of known pI were obtained from a laboratory strain of E. coli RLUH 20 (PI 5.4) and P. paucimobilis (PI 4.6) (5).
Sliscc~ptibility testing. Resistance phenotypes were determined with a controlled disc diffusion method and MIC by the "E" test method (AB Biodisk, Solna, Sweden) (6) . Susceptibilities were performed on both Iso-Sensitest agar (Oxoid Ltd., Basingstoke, UK) and a minimal growth medium (7) buffered with 0.1 M MOPS to pH 6.0, 6.5, 7.0, 7.5, and 8.0. This HBMM permits a reliable maintenance of pH during incubation. Plates were incubated overnight at 37°C in air and in 5% COz in air. Preincubation and postincubation pH of agar from uninoculated areas and areas scraped free of bacterial growth were determined with a surface-reading electrode.
@-Lactatnase extraction. Overnight bacterial growth was suspended from test media in 0.1 M potassium phosphate buffer, pH 7.0. Sonication was performed for up to 5 x 30 s pulses with samples immersed in an ice-water slurry. Cell-free sonicates were prepared by centrifugation at 13 000 rpm for 10 min and sterilized by filtration through a 0.22-pm disposable filter (Millipore Ltd., Molsheim, France). Protein concentrations was determined by the method of Lowry et al. (8) . Supernatants were stored at -70°C. @-Lactamase activity was determined for isolates grown in air, in 5% C 0 2 in air, and in the presence of imipenem (2.0 300 CORKILL ET AL. mg/L) as an inducing agent using 100 pM nitrocefin (Oxoid Ltd.) as substrate. Specific enzyme activities were measured at 482 nm (9) , and activity of the enzyme was defined as micromoles of nitrocefin destroyed per milligram of protein. Substrate profiles were performed by the disc inactivation method (4) with 20 pL of sonicate (adjusted to 1 mg protein/mL) per disc. The 150 of the p-lactamase inhibitors clavulanic acid (SmithKline Beecham, Brentford, UK) and tazobactam (Lederle, Pearl River, NY) were determined against basal level and induced P-lactamases (10) with nitrocefin as substrate.
pl detertnination. Isoelectric focusing was performed with cellfree sonicates applied to polyacrylamide gels (pH range, 3.0-9.5). After electrophoresis, P-lactamase bands were visualized by placing a filter paper soaked in a 100 pM solution of nitrocefin on the gel. The pH gradient was calibrated with proteins of known pI (LKB, Pharmacia, Uppsala, Sweden).
Cltaracteri,-ation of otrter tnetnbrane proteins. P. ccpacia was grown at 37°C in Luria broth (Difco Ltd., Detroit, MI) (pH range, 6.0-8.0) to an absorbance of approximately 0.8 O D units at 450 nm. Bacterial membranes (inner and outer) were obtained by centrifuging sonicated lysates at 100 000 x g for 1 h at 4"C, and outer membrane fractions were obtained by centrifugation after incubation in N-lauryl sarkosinate (0.5%). SDS-PAGE was carried out (1 1) with a resolving gel composition of 9% wt/vol acrylamide (36:0.84) with 4 M urea and a stacking gel of 4.5% wt/vol acrylamide (18:0.84) (12) . Proteins were visualized with Coomassie blue.
RESULTS
At 37°C in air, all isolates appeared susceptible to piperacillin, piperacillin/tazobactam, cefpirome, and ceftazidime but varied from moderately susceptible to resistant to aztreonam, temocillin, and imipenem. Susceptibility to cefpirome and, when present, to aztreonam, temocillin, and imipenem was lost on incubation in 5% C 0 2 in air. Piperacillin, piperacillin/tazobactam, and ceftazidime activity was decreased but not eliminated. This finding was not observed with P. aerzrginosa NCTC 10662. With P. cepacia (laboratory code PC7) as a typical isolate, a decrease in susceptibility (MIC) to P-lactams when grown on HBMM was found with pH < 7.5 (Table 1) . Similar increases in p-lactam MIC occurred at pH 7.0 for all P. cepacia isolates tested. Again, the susceptibility of the control strain of P. aerlrginosa was not affected. Addition of imipenem to Iso-Sensitest agar (2.0 mg/L) antagonized all p-lactams. This is probably a result of the known ability of imipenem to induce p-lactamase expression.
Before incubation, Iso-Sensitest agar had a surface pH of 7.2, but after overnight incubation in air, uninoculated areas of the agar had a pH of 8.3 and beneath bacterial growth the pH was 9.05. In 5% CO2 in air, uninoculated areas of the agar had a pH of 7.1, and beneath the bacterial growth pH was 8. The effects of pH, incubation atmosphere, and presence of imipenem as an inducing agent on p-lactamase activity on isolate PC7 are summarized in Table 2 . Incubation in C 0 2 increased the aerobic basal level of p-lactamase production by 10-fold and the presence of imipenem by 180-fold. The p-lactamase activity of 12 of 14 other P. cepacia isolates was increased by 200-1 300% by incubation in C02. For the remaining two isolates p-lactamase activity was increased by 50%. Incubation of PC7 in air produced a single P-lactamase band at pI 7.7. Incubation in 5% C 0 2 in air induced two further bands of pI 6.5 and 8.2. On HBMM, expression of p-lactamase was pH dependent. With growth at pH 8.0, a band of p-lactamase was not detected at pI 7.9, and only a trace was detectable at pH 6.5. Three bands at pI of 6.5, 7.9, and 8.2 were detected with growth at pH < 7.0. Multiple, strongly staining bands of p-lactamase activity were detected in sonicates from imipenem-induced cultures. Specific enzyme activity (micromoles of nitrocefin hydrolyzed per milligram of protein) did not alter with pH. Regardless of cultural conditions, all P-lactamases were susceptible to both clavulanate and tazobactam inhibition as measured by IJo values.
With the disc inactivation test (Table 3) , the basal level of aerobic p-lactamase from PC7 had minimal activity against the p-lactam substrates. Enzymes induced by growth in 5% C02 in air showed greater activity toward 1st-and 2nd-generation cephalosporins, including cefuroxime. Imipenem-induced P-lactamase showed extra activity toward the 3rd-generation cephalosporins, cefotaxime and ceftizoxime, and the monobactam, aztreonam.
Resistance to piperacillin, piperacillin/tazobactam, and ceftazidime correlated with cultural conditions that were associated with expression of a p-lactamase of pI 7.9. However, the methodologic procedure used did not demonstrate marked hydrolysis of either piperacillin or ceftazidime by sonicates of bacteria grown in the presence of imipenem or from strains grown on HBMM at pH < 7.5 (i.e. those containing P-lactamase of pI 7.9). SDS-PAGE of the outer membranes of PC7, grown over the pH range of 6.0 to 8.0, showed a single 36-kD porin with no discernible difference in bands or intensity in bacteria grown at each pH.
DISCUSSION
P. cepacia has emerged as an important pathogen associated with severe and often fatal infection in children and adults with cystic fibrosis (1, 2, 13). Institution of the most appropriate antimicrobial chemotherapy is of major importance in managing such infections (3, 14) . Such therapy is often guided by in virro tests of antimicrobial sensitivity. Because alterations in pH have been shown to alter apparent antimicrobial activity (15) it is unlikely that these conditions are present at all sites of infection in the body.
In the present study the activities of ceftazidime, piperacillin, piperacillin/tazobactam, and cefpirome against P. cepacia were greatly decreased when it was grown in 5% C 0 2 in air rather than in air alone. Although the MIC of these antibiotics increased by 10-to 30-fold when grown on Iso-Sensitest agar in C 0 2 , the MIC of ceftazidime (6 mg/L), piperacillin (8 mg/L), and piperacillin/tazobactam (12 mg/L) were still below the cutoff for resistance ( I 6 mg/L). However, bacterial growth in air produced a surface pH of 9.05 on agar, which was decreased to pH 8.2 when grown in 5% C 0 2 in air. When buffered growth medium was used, bacterial growth did not result in a change in pH of the medium whether or not the atmosphere was enriched with C02. At pH 7.5 or 8.0, incubation in the presence of C 0 2
ISo value (pg/mL) increased MIC, and at pH 7.5, piperacillin (MIC 32 mg/L) and piperacillin/tazobactam (MIC > 256 mg/L) were rendered clinically inactive. At pH 7.0 or below, each of the four agents had MIC greater than 256 mg/L whether or not the atmosphere was enriched with C02. Such dramatic changes were not observed when P. aerzcginosa was grown under these various conditions. This finding indicates first that the effect is specific to P. ccc.prrcia and second that the effect is not due to instability of the Plactams at different pH and CO2 concentrations. Mechanisms of resistance to P-lactams include enzymic degradation of the antibiotic by p-lactamases or exclusion-of the antibiotic from its site of action by impermeability. In the latter case, resistance to Plactams in P. cepacia has been shown to be associated with mutations of outer membrane protein (porins) genes (18) . We were unable to detect any change in expression of outer membrane proteins, in particular in the 36 kD porin in our isolates under the different growth conditions.
In contrast, incubation of each of the P. c~.pacia isolates in a C02-enriched atmosphere resulted in a n increased expression of P-lactamase activity. For two isolates this resulted only in a 50% increase in P-lactamase activity; however, both these isolates had higher basal rates of enzyme production. Incubation of our standard strain, PC7 in 5% COz in air, resulted in a 10-fold increase in P-lactamase activity. This increase was accompanied by the bacterium becoming resistant to most p-lactam antibiotics. The P-lactamase was also inducible by imipenem but to a much greater extent. The P-lactamase induced by growth in a C02-enriched atmosphere was able to inactivate 1st-and 2nd-generation cephalosporins but not 3rd-generation cephalosporins such as ceftazidime or cefotaxime. O n isoelectric focusing, P. cc.pacia PC7 was found to produce one p-lactamase band of pl 7.7 when grown in air, whereas in COz-enriched air three bands of pl 6.5, 7.7, and 8.2 were seen. Induction by subinhibitory concentrations of imipenem (2 mg/L) resulted in hypcrproduction of Plactamase and new p-lactamase bands. In particular a 8-lactamase of pI 7.9 was produced by imipenem induction and growth at pH < 7.5. P-Lactamases with pIs in this range in P. ccpacia have been reported but not fully characterized previously (14) . Our P-lactamase(s) has the characteristics of a cephalosporinase, and all enzyme activity, regardless of inducing conditions, was inhibitable by clavulanate and tazobactam. This places the Plactamase in group 2e (cephalosporinases inhibited by low concentrations of clavulanic acid) in the classification scheme as described by Bush (19) . A P-lactamase capable of hydrolyzing cefuroxime but inhibitable by clavulanate has been described previously in P. cepacia, but this enzyme has a pI of 9.3 (20) .
Hyperproduction of P-lactamase does not completely explain the development of resistance to P-lactams after growth of P. cepacia in C02-enriched air because the enzyme could not inactivate ceftazidime or piperacillin. Although we were able to detect no quantitative change in the expression of the porin, this would not preclude minor structural changes that might lead to a decrease in pore size and thus impermeability (2 1). However, the 4th-generation cephalosporin cefpirome orientates with a narrow cross-sectional area and would be expected to be relatively unaffected by decreases in porin size. Incubation of P. cepacia in C 0 2 or at low pH greatly decreased the efficacy of cefpirome. It is possible, however, that a combination of changes in ponns and hyperproduction of 0-lactamase could act synergistically to enhance resistance to p-lactams (22) .
From the foregoing it is clear that in vitro tests ofantimicrobial susceptibility alter under different growth conditions. In the present study growth of P. cepacia in C02-enriched air or a pH < 7.5 resulted in induction of p-lactamase activity and development of resistance to most P-lactams. The atmospheric concentration of CO2 is 0.003%, whereas that in the alveoli is 5-6%, similar to the concentration used by us to induce P-lactam resistance and p-lactamase production. Little information exists on alveolar C02 concentrations in cystic fibrosis; however, it is known that exertional hypercapnia occurs in patients with advanced stage cystic fibrosis as a result of chronic airflow limitation (23). Thus, it is possible that patients with advanced cystic fibrosis and P. cepacia infection might have even higher alveolar C01 concentrations. Expectorated sputum from patients with acute exacerbations of chronic bronchitis were found to have an average pH of 7.8 (24) . However, endobronchial pH in patients with gram-negative pneumonia was found to average 6.6 1, and endobronchial pH in patients with chronic lung disease and in normal subjects were 6.62 and 6.58, respectively (25) . Unfortunately, no information on sputum pH is available for patients with cystic fibrosis. However, it does seem likely the conditions of pH and COz concentration at the site of P. cepacia infection in patients with cystic fibrosis are likely to result for our 15 isolates in hyperproduction of p-lactamases and thus clinical resistance to p-lactam antibiotics. It is noteworthy that despite conventional in vitro sensitivity to ceftazidime (MIC < 4 mg/L), of 18 episodes of P. cepacia infection in patients with cystic fibrosis treated with intravenous ceftazidime, only six resulted in clinical improvement and in only one case was the number of bacteria decreased (3).
